GE Healthcare and GMS Taiwan sign exclusive license agreement for Vizamyl in Taiwan

GE Healthcare and Global Medical Solutions Taiwan signed an exclusive license agreement to manufacture and commercialize Flutemetamol F-18 Injection (Vizamyl) in Taiwan. GMS Taiwan plans to file an NDA by end of 2021.

“GE Healthcare and Global Medical Solutions Taiwan have signed an exclusive license agreement to manufacture and commercialize Flutemetamol F-18 Injection in Taiwan.”globalmedicalsolutions.com

• 1 source
• globalmedicalsolutions.comGE Healthcare and GMS Taiwan sign exclusive license agreement for Flutemetamol F-18 Injection (Vizamyl™) in Taiwan | Global Medical SolutionsekidesignsApr 12, 2021

Summarized from public sources; check the original articles before acting on it.